Dr. Sangeetha Nimmagadda, MD
- Medicare services, 2024
- 12,262
- Medicare patients, 2024
- 124
- Part D claims, 2024
- 219
- Clinical trials
- 4
- Hospital affiliations
- 4
- Practice address
- 1800 Sherman Ave, Evanston, IL 60201
- Practice phone
- Call (847) 492-3040
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
North Shore Infusion Ltd
Evanston, Illinois
Find Dr. Nimmagadda's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Sangeetha Nimmagadda is a hematologist and oncologist in Evanston, Illinois
Dr. Nimmagadda practices at North Shore Infusion Ltd in Evanston, Illinois.
Dr. Nimmagadda's NPI, 1851594725, was assigned on June 7, 2007. Dr. Nimmagadda graduated from Jefferson Medical College of Thomas Jefferson University in 2004. Dr. Nimmagadda holds Illinois license 036.125493.
- NPI
- 1851594725NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3577752096
- NPI enumeration date
- June 7, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (847) 492-3040
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 48
- Medical school graduation
- 2004
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Sangeetha Nimmagadda practices at North Shore Infusion Ltd in Evanston, Illinois
Dr. Nimmagadda's primary practice is North Shore Infusion Ltd, at 1800 Sherman Ave, Evanston, IL 60201 in Cook County. The practice phone is (847) 492-3040.
- North Shore Infusion Ltd1800 Sherman Ave, Evanston, IL 60201 · Cook CountyPhone(847) 492-3040
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Sangeetha Nimmagadda is affiliated with 6 sites of care and 1 medical group
Dr. Nimmagadda's primary practice is North Shore Infusion Ltd in Evanston, Illinois. Dr. Nimmagadda is also affiliated with Evanston Hospital. The medical group on file is North Shore Infusion. Dmand AI also links Dr. Nimmagadda to 3 more hospitals and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Sangeetha Nimmagadda's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nimmagadda practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| North Shore Infusion Ltd | Available with a free account |
| +5 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Sangeetha Nimmagadda is one of 563 hematologists and oncologists in Illinois
Hematology and oncology is Dr. Nimmagadda's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Nimmagadda is licensed in Illinois.
Specialties and state licenses
- Hematology and oncology, IllinoisPrimary
Hematologists and oncologists near Dr. Nimmagadda
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Sangeetha Nimmagadda billed Medicare for 12,262 services in 2024
CMS data shows 12,262 Medicare services from Dr. Nimmagadda across 15 procedure codes in 2024, for 124 Medicare patients. Medicare paid $132,895 for them. Every service was in an office.
Dr. Nimmagadda's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 15,1782024: 10,66130%
- Tests and treatments
- 2023: 8842024: 69821%
- Other services
- 2023: 4322024: 52822%
- Office and hospital visits
- 2023: 4362024: 37514%
Dr. Nimmagadda compared with the Illinois median for hematologists and oncologists, 2024
- Dr. Nimmagadda
- Illinois median
- Medicare services
- 12,262vs 1,05611.6 times
- Medicare patients
- 124vs 28256% below
- Part D claims
- 80vs 32876% below
Medians across 547 hematologists and oncologists in Illinois with Dmand AI profiles that report each measure.
Dr. Nimmagadda's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Nimmagadda?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Nimmagadda and other hematologists and oncologists in Illinois.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Sangeetha Nimmagadda treated 124 Medicare patients in 2024, average age 70
CMS counts 124 Medicare patients who saw Dr. Nimmagadda in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have cancer, and 62% have high cholesterol. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Nimmagadda's median patient age at 61, with 69% women.
Dr. Nimmagadda's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Nimmagadda's Medicare patients by sex, 2024
- Women8770%
- Men3730%
Chronic conditions among Dr. Nimmagadda's Medicare patients, 2024
- Cancer75%
- High cholesterol62%
- High blood pressure56%
- Arthritis42%
- Anxiety31%
- Ischemic heart disease28%
- Osteoporosis28%
- Mood disorders27%
Share of Medicare patients with each condition. A patient can have several.
Dr. Nimmagadda's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 61
Patient panel by sex, all payers
- Women69%
- Men29%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Sangeetha Nimmagadda wrote 219 Medicare Part D claims in 2024
In 2024, Dr. Nimmagadda wrote 219 Medicare Part D claims for 44 patients. 81% of them were for generic drugs. CMS names the drug for 80 of them, across 5 drugs with 11 or more claims each, at $190,454 in total drug cost. In 2023, CMS named 61 claims across 4 drugs.
Dr. Nimmagadda's Part D claims by kind of drug, 2024
- Generic177 claims81%
- Brand-name42 claims19%
Dr. Nimmagadda's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Nimmagadda's Part D claims, 2024
- Antibiotics6%14 of 219 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 612024: 8031%
Drugs named by CMS: 5 in 2024, 4 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Sangeetha Nimmagadda offers telehealth to Medicare patients
Dr. Nimmagadda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nimmagadda as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Sangeetha Nimmagadda has worked on 4 clinical trials
Dmand AI links Dr. Nimmagadda to 4 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic. National Cancer Institute (NCI) sponsors the most, 3.
Conditions in Dr. Nimmagadda's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
Investigators on the most trials with Dr. Nimmagadda
- William Jude Charles, MD4 shared trials
- David Kendall Goebel, MD4 shared trials
- Donald E. Goodin, MD4 shared trials
Recent clinical trials with Dr. Nimmagadda
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) (opens in a new tab)
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) (opens in a new tab)
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) (opens in a new tab)
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Sangeetha Nimmagadda received $8,985 in industry payments from 2017 to 2025
CMS Open Payments shows 279 general payments to Dr. Nimmagadda from 39 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 65% of the total. Bristol-Myers Squibb Company paid the most, $2,885.
General payments to Dr. Nimmagadda by program year, 2017 to 2025
General payments to Dr. Nimmagadda by kind, 2017 to 2025
- Food and beverage$5,83865%
- Consulting fees$2,64229%
- Speaker and faculty fees$4004%
- Education$1051%
Companies that paid Dr. Nimmagadda the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Sangeetha Nimmagadda graduated from Jefferson Medical College of Thomas Jefferson University
Dr. Nimmagadda graduated from Jefferson Medical College of Thomas Jefferson University in 2004.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Sangeetha Nimmagadda's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Sangeetha Nimmagadda
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Sangeetha Nimmagadda's NPI number?
Dr. Sangeetha Nimmagadda's NPI number is 1851594725. It was assigned on June 7, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Sangeetha Nimmagadda?
Dr. Sangeetha Nimmagadda is a hematologist and oncologist in Evanston, Illinois. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Sangeetha Nimmagadda practice?
Dr. Nimmagadda practices at 1800 Sherman Ave, Evanston, IL 60201. Dr. Nimmagadda's primary practice is North Shore Infusion Ltd in Evanston, Illinois. Dmand AI also links Dr. Nimmagadda to 3 hospitals and 1 group practice or clinic.
What is Dr. Sangeetha Nimmagadda's office phone number?
The practice phone on file for Dr. Nimmagadda is (847) 492-3040.
What is Dr. Sangeetha Nimmagadda's medical license number?
Dr. Nimmagadda holds Illinois license 036.125493.
Which hospitals is Dr. Sangeetha Nimmagadda affiliated with?
Dr. Nimmagadda is affiliated with Evanston Hospital. Dmand AI links Dr. Nimmagadda to 3 more hospitals.
What medical group is Dr. Sangeetha Nimmagadda part of?
Dr. Nimmagadda is linked to North Shore Infusion.
Does Dr. Sangeetha Nimmagadda accept Medicare?
Yes. CMS data shows Dr. Nimmagadda billed Medicare for 12,262 services in 2024, and Dr. Nimmagadda accepts Medicare assignment.
Does Dr. Sangeetha Nimmagadda offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Nimmagadda as offering telehealth services.
How many Medicare patients does Dr. Sangeetha Nimmagadda see?
CMS counts 124 Medicare patients who saw Dr. Nimmagadda in 2024, with an average age of 70.
Show 6 more questionsShow fewer questions
What services does Dr. Sangeetha Nimmagadda bill to Medicare?
In 2024, Dr. Nimmagadda's most billed Medicare services were injected or infused drug (J1453), injected or infused drug (J2469) and injected or infused drug (J1100).
Where did Dr. Sangeetha Nimmagadda go to medical school?
Dr. Nimmagadda graduated from Jefferson Medical College of Thomas Jefferson University in 2004.
What drugs does Dr. Sangeetha Nimmagadda prescribe most?
In 2024 Medicare Part D data, Dr. Nimmagadda's most prescribed drugs by claims were Letrozole, Tamoxifen Citrate and Abiraterone Acetate.
Has Dr. Sangeetha Nimmagadda received payments from drug or device companies?
CMS Open Payments shows $8,985 in general payments to Dr. Nimmagadda from 39 companies from 2017 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Sangeetha Nimmagadda been practicing?
Dr. Nimmagadda graduated from medical school in 2004, 22 years ago.
Does Dr. Sangeetha Nimmagadda do research?
Dr. Nimmagadda has worked on 4 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Illinois by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card